StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.90+0.08 (+9.83%)

Close on Nov 18, 2026Market cap $104.20MP/E –Yield –

NovaBridge Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

NovaBridge Biosciences's profit margin for the twelve months ending Dec 31, 2019 was -4839.8%. For fiscal 2023 it was -5302.0%, against -2648.7% the year before. The highest annual figure on record is 30.5% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-5302.0%−2653.3
FY2021Dec 31, 2021-2648.7%−2679.2
FY2020Dec 31, 202030.5%+4870.4
FY2019Dec 31, 2019-4839.8%−4090.8
FY2018Dec 31, 2018-749.0%+1831.8
FY2017Dec 31, 2017-2580.8%–

More NovaBridge Biosciences figures

See a number that looks wrong?